Histone deacetylase inhibitor NVP-LAQ824 has significant activity against myeloid leukemia cells in vitro and in vivo

Myeloid Leukemia ◽

Leukemia Cells ◽

Significant Activity ◽

MYB down-regulation enhances sensitivity of U937 myeloid leukemia cells to the histone deacetylase inhibitor LBH589 in vitro and in vivo

Cancer Letters ◽

10.1016/j.canlet.2013.09.022 ◽

2014 ◽

Vol 343 (1) ◽

pp. 98-106 ◽

Cited By ~ 7

Author(s):

Ping Ye ◽

Liang Zhao ◽

Crystal McGirr ◽

Thomas J Gonda

Keyword(s):

Histone Deacetylase ◽

Myeloid Leukemia ◽

Leukemia Cells ◽

Down Regulation ◽

CRA-026440: a potent, broad-spectrum, hydroxamic histone deacetylase inhibitor with antiproliferative and antiangiogenic activity in vitro and in vivo

Molecular Cancer Therapeutics ◽

10.1158/1535-7163.mct-06-0042 ◽

2006 ◽

Vol 5 (7) ◽

pp. 1693-1701 ◽

Cited By ~ 19

Author(s):

Z. Alexander Cao ◽

Kathryn E. Bass ◽

Sriram Balasubramanian ◽

Liang Liu ◽

Brian Schultz ◽

...

Keyword(s):

Histone Deacetylase ◽

Broad Spectrum ◽

Antiangiogenic Activity ◽

Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivo

Journal of Hepatology ◽

10.1016/j.jhep.2011.07.013 ◽

2012 ◽

Vol 56 (1) ◽

pp. 176-183 ◽

Cited By ~ 32

Author(s):

Huanjie Shao ◽

Chun Gao ◽

Haikuo Tang ◽

Hao Zhang ◽

Lewis R. Roberts ◽

...

Keyword(s):

Histone Deacetylase ◽

Dual Targeting ◽

Effects of FK228, a novel histone deacetylase inhibitor, on human lymphoma U-937 cells in vitro and in vivo

Biochemical Pharmacology ◽

10.1016/s0006-2952(02)01261-3 ◽

2002 ◽

Vol 64 (7) ◽

pp. 1079-1090 ◽

Cited By ~ 63

Author(s):

Yuka Sasakawa ◽

Yoshinori Naoe ◽

Takeshi Inoue ◽

Tatsuya Sasakawa ◽

Masahiko Matsuo ◽

...

Keyword(s):

Histone Deacetylase ◽

Deacetylase Inhibitor ◽

Human Lymphoma

Abstract B009: The histone deacetylase inhibitor pracinostat and its metabolite SB991 are active as single agents and in combination with 5-azacitidine in acute myeloid leukemia cells

10.1158/1535-7163.targ-19-b009 ◽

2019 ◽

Author(s):

Afua Adjeiwaa Mensah ◽

Filippo Spriano ◽

Eugenio Gaudio ◽

Annalisa Bonifacio ◽

Emanuela Lovati ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Histone Deacetylase ◽

Myeloid Leukemia ◽

Leukemia Cells ◽

Deacetylase Inhibitor ◽

Acute Myeloid Leukemia Cells ◽

Acute Myeloid

Histone deacetylase inhibitor MPT0B291 suppresses Glioma Growth in vitro and in vivo partially through acetylation of p53

International Journal of Biological Sciences ◽

10.7150/ijbs.45505 ◽

2020 ◽

Vol 16 (16) ◽

pp. 3184-3199

Author(s):

Batsaikhan Buyandelger ◽

Eli E Bar ◽

Kuo-Sheng Hung ◽

Ruei-Ming Chen ◽

Yung-Hsiao Chiang ◽

...

Keyword(s):

Histone Deacetylase ◽

Deacetylase Inhibitor ◽

Glioma Growth

Growth inhibition of pancreatic cancer cells by histone deacetylase inhibitor belinostat through suppression of multiple pathways including HIF, NFkB, and mTOR signaling in vitro and in vivo

Molecular Carcinogenesis ◽

10.1002/mc.22024 ◽

2013 ◽

Vol 53 (9) ◽

pp. 722-735 ◽

Cited By ~ 37

Author(s):

Wenwen Chien ◽

Dhong Hyun Lee ◽

Yun Zheng ◽

Peer Wuensche ◽

Rosie Alvarez ◽

...

Keyword(s):

Pancreatic Cancer ◽

Growth Inhibition ◽

Cancer Cells ◽

Histone Deacetylase ◽

Mtor Signaling ◽

Pancreatic Cancer Cells ◽

Phosphodiesterase inhibitor, pentoxifylline enhances anticancer activity of histone deacetylase inhibitor, MS-275 in human breast cancer in vitro and in vivo

European Journal of Pharmacology ◽

10.1016/j.ejphar.2015.07.048 ◽

2015 ◽

Vol 764 ◽

pp. 508-519 ◽

Cited By ~ 6

Author(s):

Saranya Nidhyanandan ◽

Thippeswamy S. Boreddy ◽

Kothapalli B. Chandrasekhar ◽

Neetinkumar D. Reddy ◽

Nagaraj M. Kulkarni ◽

...

Keyword(s):

Breast Cancer ◽

Anticancer Activity ◽

Histone Deacetylase ◽

Human Breast Cancer ◽

Phosphodiesterase Inhibitor ◽

Human Breast ◽

Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-019-02980-6 ◽

2019 ◽

Vol 145 (9) ◽

pp. 2411-2411

Author(s):

Francesco Marampon ◽

Flavio Leoni ◽

Andrea Mancini ◽

Ilaria Pietrantoni ◽

Silvia Codenotti ◽

...

Keyword(s):

Histone Deacetylase ◽

In Vivo Models ◽

Human Glioblastoma ◽

MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo

Molecular Cancer Therapeutics ◽

10.1158/1535-7163.mct-07-2026 ◽

2008 ◽

Vol 7 (4) ◽

pp. 759-768 ◽

Cited By ~ 225

Author(s):

Marielle Fournel ◽

Claire Bonfils ◽

Yu Hou ◽

Pu Theresa Yan ◽

Marie-Claude Trachy-Bourget ◽

...

Keyword(s):

Antitumor Activity ◽

Histone Deacetylase ◽

Broad Spectrum ◽